ARCHIVES

Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”

This article is from The Cancer Letter archive.

Vol. 37 No. 18 | May 6, 2011

Download PDF Visit The Full Archive

Related Articles

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

NCI advisors table proposed $186.5 million nanotechnology research program. NCI proposed to fund three to five “centers for cancer nanotechnology excellence,” a coordinating center, and training programs. Board members said they needed more time, information, to make decision. NCI director asked board to “think big” about nanotechnology. Deputy director called nanotechnology program “transformational.”

July 2, 2004

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

In Brief: Hong, Posner Awarded ACS Research Professorships; Hawaii Wins Center Grants

July 26, 1996

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007